Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: ciprofloxacin attending: chief complaint: respiratory depression major surgical or invasive procedure: emg, tracheostomy history of present illness: 73f transferred from osh for neuro eval and trach/peg. initially presented with gangrenous ileum-->resected, extubated and transferred to floor. on , had cardiac arrest and successfully resuscitated. post-code, able to mae and follow commands. had some arf which has since resolved. treated for ?rml pna with cefotetan and clinda . had some diarrhea that resolved with changing her tfeeds. also with new hyperglycemia and now on insulin. extubated but reintubated for hypercarbic resp failure. while extubated, had areflexia and weakness in all 4 extremities. ck and tensilon test wnl. bu , no improvement in quadraparesis but reflexes, sensation and cn intact. by , able to answer questions by nodding yes/no and track with eyes. did well on tpiece trial so extubated but reintubated that same day. past medical history: cad s/p mi s/p lad stent , depression, htn, oa, ibs, tah, bladder suspension social history: husband: lives in family history: father with but details unknown physical exam: vs: t 98.5 hr 94 bp 159/68 rr 17 99% on ac 500x12@ 30% peep 5 g: intubated, eyes open to voice heent: opens eyes, perrla lungs: decr bs at bases cv: rrr nl s1 s2 abd: soft, nt, nd, bs+ ext: no edema neuro: flaccid bl upper and lower ext; bl foot drop; opens eyes to voice; moves neck; breathes spontaneously on ps; no babinski; dtr intact throughout pertinent results: 04:28am blood wbc-8.6 rbc-3.30* hgb-9.7* hct-28.9* mcv-88 mch-29.5 mchc-33.6 rdw-15.5 plt ct-191 05:13pm blood hct-28.6* 05:00am blood wbc-7.5 rbc-3.21* hgb-9.6* hct-28.1* mcv-87 mch-30.1 mchc-34.4 rdw-15.6* plt ct-203 06:59pm blood wbc-9.4 rbc-3.44* hgb-10.6* hct-30.2* mcv-88 mch-30.8 mchc-35.1* rdw-15.7* plt ct-235 05:29am blood wbc-7.6 rbc-2.91* hgb-8.6* hct-26.7* mcv-92 mch-29.6 mchc-32.2 rdw-15.0 plt ct-255 11:48am blood hct-27.3* 04:00am blood wbc-7.5 rbc-2.99* hgb-9.2* hct-26.8* mcv-90 mch-30.8 mchc-34.4 rdw-14.9 plt ct-255 02:15am blood wbc-7.0 rbc-3.26* hgb-9.5* hct-29.8* mcv-92 mch-29.3 mchc-32.0 rdw-15.0 plt ct-321 02:45pm blood wbc-7.4 rbc-3.31* hgb-10.0* hct-30.3* mcv-91 mch-30.2 mchc-33.1 rdw-14.6 plt ct-335 02:15am blood neuts-80.8* lymphs-11.6* monos-4.2 eos-3.0 baso-0.4 04:28am blood plt ct-191 05:00am blood plt ct-203 06:59pm blood plt ct-235 05:29am blood plt ct-255 04:00am blood plt ct-255 04:00am blood pt-12.6 ptt-36.0* inr(pt)-1.0 02:15am blood plt ct-321 02:15am blood pt-12.8 ptt-29.2 inr(pt)-1.1 02:45pm blood plt ct-335 02:45pm blood pt-12.9 ptt-33.0 inr(pt)-1.1 02:45pm blood fibrino-596* 12:47pm blood k-3.8 04:28am blood glucose-74 urean-25* creat-0.8 na-143 k-2.7* cl-103 hco3-32* angap-11 05:12pm blood k-4.0 05:00am blood glucose-165* urean-27* creat-0.8 na-141 k-3.0* cl-103 hco3-31* angap-10 06:59pm blood glucose-152* urean-24* creat-0.8 na-141 k-3.5 cl-103 hco3-31* angap-11 05:29am blood glucose-154* urean-24* creat-0.7 na-142 k-3.0* cl-104 hco3-31* angap-10 11:48am blood k-3.6 04:00am blood glucose-189* urean-25* creat-0.7 na-138 k-4.9 cl-103 hco3-27 angap-13 12:00am blood k-2.7* 02:15am blood glucose-124* urean-29* creat-0.7 na-138 k-3.3 cl-101 hco3-29 angap-11 02:45pm blood glucose-107* urean-29* creat-0.7 na-139 k-3.8 cl-103 hco3-29 angap-11 02:45pm blood alt-57* ast-41* ck(cpk)-39 alkphos-161* totbili-0.3 02:45pm blood ck-mb-4 ctropnt-0.09* 04:28am blood calcium-8.4 phos-3.4 mg-1.8 06:59pm blood calcium-8.8 phos-2.9 mg-1.6 02:15am blood calcium-7.9* phos-3.8 mg-2.0 02:45pm blood albumin-2.3* calcium-8.0* phos-3.2 mg-1.6 02:15am blood tsh-1.4 12:00pm blood type-art po2-161* pco2-44 ph-7.48* calhco3-34* base xs-9 04:15am blood type-art temp-37.2 rates-/16 tidal v-400 peep-5 o2-30 po2-147* pco2-42 ph-7.50* calhco3-34* base xs-8 intubat-intubated vent-spontaneou 08:44am blood type-art temp-37.7 rates-/30 tidal v-300 peep-5 o2-30 po2-148* pco2-46* ph-7.44 calhco3-32* base xs-6 intubat-intubated vent-spontaneou 02:56pm blood type-art temp-36.9 rates- tidal v-550 peep-5 o2-30 po2-126* pco2-44 ph-7.45 calhco3-32* base xs-6 -assist/con intubat-intubated brief hospital course: pt admitted to micu for ventilatory support. uti discovered on admission: pseudomonas tx'd with zosyn, vre tx'd with macrodantin. pt required multiple medications for bp control. mri head and neck performed, showed no watershed infarcts and nl neck. emg limited due to electrical interference, but determined that there is electrophysiological evidence for at least a moderately severe generalized sensorimotor polyneuropathy, predominantly axonal. pt kept on vent support throughout stay and upon reception of tracheostomy, is d/c back to osh for further rehab. prior to d/c, pt developed fever felt to be due to line infection (c-line), with cultures pending. line was d/c and is d/c to osh on vanco. on d/c pt vent settings: psv 12/5 fio2 30%. pt is beginning to have some movement in upper and lower extremities. as per iv pulmonology, trach sutures can be removed in 3 days. pt completed 7 day course ab for pseudomonas and enterococcus uti; however, pt spiked . urine culture () grew gm+ cocci, and pseudomonas, reflecting possible resistance. pt should have urine cultures, gm stains upon admission, for re-evaluation. upon d/c, were following temp spikes with blood cultures, no growth to date. medications on admission: ambien, raloxifone, estrace, ntg, toprol xl 100, diovan 80, kcl, zocor 10, dexamethasone 40, centrum, caltrate, asa, foltx discharge medications: 1. citalopram hydrobromide 20 mg tablet sig: two (2) tablet po qd (once a day). 2. lisinopril 20 mg tablet sig: two (2) tablet po qd (once a day). 3. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po qd (once a day). 4. nitroglycerin transdermal 0.6 mg/hr patch 24hr sig: one (1) transdermal q24h (every 24 hours). 5. amlodipine besylate 5 mg tablet sig: one (1) tablet po qd (once a day). 6. lansoprazole 30 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po qd (once a day). 7. nitrofurantoin macrocrystal 50 mg capsule sig: one (1) capsule po qid (4 times a day) for 1 days. 8. heparin sodium (porcine) 5,000 unit/ml solution sig: one (1) injection q8h (every 8 hours). 9. hydralazine hcl 25 mg tablet sig: two (2) tablet po q6h (every 6 hours). 10. acetaminophen 160 mg/5 ml elixir sig: po q4-6h (every 4 to 6 hours) as needed. 11. metoprolol tartrate 25 mg tablet sig: five (5) tablet po tid (3 times a day). 12. trazodone hcl 50 mg tablet sig: 0.5 tablet po hs (at bedtime) as needed. 13. insulin regular human 300 unit/3 ml syringe sig: per sliding scale subcutaneous four times a day. 14. piperacillin-tazobactam 4-0.5 g recon soln sig: one (1) recon soln intravenous q8h (every 8 hours) for 1 days. 1. citalopram hydrobromide 20 mg tablet sig: two (2) tablet po qd (once a day). 2. lisinopril 20 mg tablet sig: two (2) tablet po qd (once a day). 3. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po qd (once a day). 4. nitroglycerin transdermal 0.6 mg/hr patch 24hr sig: one (1) transdermal q24h (every 24 hours). 5. amlodipine besylate 5 mg tablet sig: one (1) tablet po qd (once a day). 6. lansoprazole 30 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po qd (once a day). 8. heparin sodium (porcine) 5,000 unit/ml solution sig: one (1) injection q8h (every 8 hours). 9. hydralazine hcl 25 mg tablet sig: two (2) tablet po q6h (every 6 hours). 10. acetaminophen 160 mg/5 ml elixir sig: po q4-6h (every 4 to 6 hours) as needed. 11. metoprolol tartrate 25 mg tablet sig: five (5) tablet po tid (3 times a day). 12. trazodone hcl 50 mg tablet sig: 0.5 tablet po hs (at bedtime) as needed. 13. insulin regular human 300 unit/3 ml syringe sig: per sliding scale subcutaneous four times a day. discharge disposition: extended care discharge diagnosis: critical illness polyneuropathy, cad s/p mi s/p lad stent, depression, htn, oa, ibs, tah, bladder suspension discharge condition: stable-intubated discharge instructions: see discharge summary followup instructions: to be determined upon d/c from other hospital procedure: continuous invasive mechanical ventilation for 96 consecutive hours or more enteral infusion of concentrated nutritional substances other bronchoscopy temporary tracheostomy transfusion of packed cells diagnoses: anemia, unspecified urinary tract infection, site not specified congestive heart failure, unspecified unspecified essential hypertension coronary atherosclerosis of unspecified type of vessel, native or graft percutaneous transluminal coronary angioplasty status old myocardial infarction unspecified hereditary and idiopathic peripheral neuropathy chronic respiratory failure 

Answer: The patient is high likely exposed to